Three of the major categories of indications for TNF inhibitors included gastrointestinal (GI) indications such as inflammatory bowel disease and irritable bowel syndrome, joint indications such as rheumatoid arthritis and ankylosing spondylitis, and skin indications such as dermatitis and psoriasis. This evidence concerns the gene TNF and inflammatory bowel disease.